Phase 2 Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years old (male or female) who have been diagnosed with fatty liver disease, confirmed through an ultrasound scan of the upper abdomen
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People who drink more than 30 grams of alcohol per day on average (for men) or more than 20 grams per day on average (for women) (confirm with trial site for what this means in standard drinks)
- People whose liver disease is caused by something other than fatty liver, such as viral hepatitis, a reaction to medication, or an autoimmune condition affecting the liver
- People living with chronic kidney disease, a condition affecting the parathyroid glands (either overactive or underactive), or heart failure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The change in the degree of steatosis in the ultra sound and the change in fibrosis risk scores are the primary endpoint.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.